Masimo Corp is a global medical technology company that specializes in non-invasive monitoring solutions for patients
The company is best known for its innovative pulse oximetry technology, which measures blood oxygen levels and vital signs in real-time, providing healthcare professionals with critical data to enhance patient care. Masimo's products are designed to improve patient outcomes and safety across a wide range of clinical settings, including hospitals, outpatient facilities, and home care environments. In addition, the company develops advanced monitoring devices and software that integrate with existing medical systems, thereby optimizing workflows and enhancing the overall efficiency of healthcare delivery.
The mid-cap-centric S&P 400 index has rallied 21.4% year-to-date. Within the mid-cap space, a handful of stocks have the potential to become large-caps in 2025. Here's why they may be worth consideration.
